AIM Vaccine's serum-free iterative rabies vaccine passes NMPA inspections, approaching commercialization. It shows excellent safety and efficacy, poised to fill global market gap.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.